DuPont Spin-offs Biomaterials Unit to China Huafon Group

Healthcare Author: Fuller Wang, Cision Jun 02, 2022 09:15 AM (GMT+8)

The Biomaterials business unit recorded net sales of approximately USD 200 million in 2021.

biotechnology

On June 2, 2022, DuPont announced the completion of the previously-announced sale of its Biomaterials business unit, effective to the Huafon Group for approximately USD 240 million. For 2021, the Biomaterials business unit recorded net sales of approximately USD 200 million. Following sales and spin-offs, DuPont now describes itself as a global innovation leader with technology-based materials and solutions. The total revenue generate by DuPont in 2021 reached USD 16.6 billion.

Founded in 1991 and headquartered in Ruian, China, the Huafon Group is one of the largest manufacturers of polyurethane materials in the world and has a broad product portfolio in adipic acid, polyester polyols, spandex filament, microfiber material, TPU and polyamide Huafon Group has more than 14,000 employees and owns multiple subsidiary companies globally in chemical, metals, finance, logistics, information technology, and trade.